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To improve symptomatic status and avoid reoperation,
122 initial and 7 repeat percutaneous transluminal coro-
nary angioplasty procedures were performed in 116 pa-
tients with disabling angina pectoris at a mean of 26.8
months (ra nge 2 to 132) after coronary bypass surgery.
Marked angiographic improvement (> 30% reduction
in diameter stenosis) was obtained in 107 (88%) of the
122 initial procedures and in all 7 repet itions. Mean
stenosis was reduced from 78 ± 13% (mean ± standard
deviation) to 25 ± 13% (p < 0.0001) and mean pressure
gradient from 49 ± 15 to 11 ± 8 mm Hg (p < 0.0001).
Complications were: emergency surgery (three pa-
tients), Q wave infarction (one patient), myocard ial in-
farction by enzyme criteria only (four patients) and non-
occluding coronary dissection (one patient). There were
In the 15 years since its initial description (I ), coronary
bypass surgery has been widely utilized as palliation for
symptomatic patients with obstructive coronary atheroscle-
rosis. Low operative mortality, immediate symptomatic
benefits and improved longevity have fostered its increasing
application. However, deterioration of symptomatic status
after surgery due to progression of disease in the native
coronary circulation and grafts remains a problem (2-7).
Recurrence or worsening of symptoms is reported in 5 to
10% of postoperative patients annually (2,6,7), and ap-
proximately 10% of patients with long-term follow-up have
required reoperation (8- 10). Even for the most experienced
surgeon, reoperations are technically difficult , mortality is
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no neurologic or peripheral vascular complications and
no early deaths. One late death occurred 14 months after
an unsuccessful but uncomplicated angioplasty proce-
dure. At a mean follow-up of 8.3 months, 88 patients
(76%) were free of angina or in improved condition. In
patients followed up for at least 6 months, evidence of
restenosis occurred in 9 (53%) of 17 saphenous veins, 1
(50%) of 2 proximal graft anastomoses, 4 (18%) of 22
distal graft anastomoses and 5 (14%) of 37 native coro-
nar y arteries.
When coronary anatom y is suitable, percutaneous
transluminal angioplasty is an attractive alternative to
reoperation in symptomatic patients with prior coronary
bypass surgery.
higher than in initial operations and complications are more
frequent (11,12).
Since the initial application of transluminal angioplasty
for the treatment of the coronary artery stenosis in human
beings by Gruentzig (13) in 1977, an alternative to surgical
revascularization of the myocardium has evolved which is
applicable in a significant number of patients with disabling
symptoms and suitable coronary angiographic pathoana-
tomy. Complication rates are low in experienced hands and
results of intermediate-term follow-up are favorable ( 14-
20). In carefully selected patients, coronary bypass surgery
may be avoided or postponed with net benefitdue to reduced
morbidity, cost and preservation of productivity (2 1,22) .
Little information is available, however, as to which patients
with a previous operation are the best candidates for per-
cutaneous angioplasty (15,23-26). Results from the Na-
tional Heart, Lung, and Blood Institute Registry indicated
that in-hospital mortality of angioplasty was increased in
patients with a previous coronary bypass operation (18, 19).
Because of this increased risk, selection criteria are needed
to identify those patients previously operated on in whom
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Figure 2. Lengthof time between bypass surgery and transluminal
dilation based on location of stenosis. CABS = coronary artery
bypass surgery, Prox Anast = proximal anastomosis (aorta to
saphenous vein); PTCA = percutaneous transluminal coronary
angioplasty.
chest roentgenogram in 9%. Eight patients were in Canad ian
Cardiovascular Society functional class I, 28 in class II, 30
in class III and 30 in class IV. The patients were selected
for angioplasty when the primary symptom producing ob-
struction to coronary blood flow appeared amenable to the
technique. In general , patients with more than one major
coronary artery suitable for bypass surgery or with multiple
segmental stenoses of vein grafts were referred for surgery.
Number of angioplasty procedures. In III of the 116
patients, angioplasty of a single stenotic segment was at-
tempted . Two patient s had two vessels dilated during the
same hospitalization , and two patients had two vessels di-
lated with intervals of 5 and 9 months between procedure s.
One patient had a single vessel angioplasty, followed at 4
months by a double vessel angioplasty. Seven patients had
repeat angiopla sty procedure s for restenosis 2 to 7 month s
after the initial procedure .
high initial success rates, few complications and good long-
term patency can be expected.
The present report deal s with our immediate and long-
term results with percutaneous translum inal angiopla sty in
patient s who have had coronary bypass surgery but have
experienced recurrence of disabling ischemi c symptoms ne-
cessitating a second revascularization procedure .
Methods
Patient Population
From January 1978 to November 1982, 116 patients who
had had prior coronary bypass surgery underwent 122 initial
coronary angioplasty procedures (Fig . 1). Seventeen pa-
tients were treated at University Hospital , ZUrich, Switzer-
land and 99 at Emory University Hospital. Atlanta , Georgia.
Their mean age was 54 .1 years (range 37 to 72); 99 (85%)
patients were men and 17 (15%) were women. The mean
interval between coronary bypass surgery and coronary an-
gioplasty was 26.8 month s (range 2 to 132). Forty-three
patients (37%) had coronary angioplasty within 6 months
and 54 (46%) within 1 year of coronary bypas s surgery (Fig.
2 ).
Clinical profile. All patients had disabling ischemic
symptoms despite treatment with nitrate s and beta-receptor
blocking drug s and many patients received calc ium antag-
onists . The clinical profile of the last 96 consecut ive patient s
was representative of the entire group : unstable angina (of
recent onset , prolonged or progre ssive) was present in 55%
of the patients , hypertension requiring therapy in 28%, his-
tory of myocardial infarction in 39%, diabetes in 16%,
smoking greater than 10 pack-years in 89%, history of hy-
perlipidemia in 23%, conge stive heart failure in 11%, Q
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Figure l. Sites of 122 first transluminal angioplasty attempts.
IMA = internal mammary artery graft.
Prox imal Anastomos is - 5
Distal Anastomosis - 34
IMA-1
Native Coronary Artery - 59
Technique of Coronary Angioplasty
Recent technical improvements. The basic techn ical
aspects of percutaneou s translumin al coronary angiopla sty
are reported elsewhere (15). Determination of coronary ar-
tery stenosis was made by measuring the diameter of the
stenotic and adjacent normal coronary artery on tracin gs of
a projected cine image , usually in three views. Recent meth-
odologic improvement s in the percutaneous angioplasty
technique include : I) guiding catheter systems with belter
torque control and 8 French size, 2) development of a 0 .8
mm diameter. low profile . 2 mm balloon dilating catheter
(USCl), 3) development of dilating catheter systems with a
central lumen through which a directable guidewire may be
passed ( 14,27) (USCI . Advanced Catheter Systems). 4) poly-
vinyl balloon catheters that withstand pressures of 12 atmo-
spheres , and 5) the appreciation that mainten ance of longer
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periods of balloon inflation of 30 to 60 seconds may be
effective when shorter periods of inflation are not (28).
Protocol. After anticoagulation with heparin, adminis-
tration of aspirin and pharmacologic dilation of the coronary
arteries with nitrates and calcium antagonists, the appro-
priate coronary artery or vein graft ostium was cannulated
with an 8 or 9 French guiding catheter and the dilating
catheter passed under dual plane fluoroscopic control across
the stenotic segment. After testing with a small amount of
contrast medium to confirm correct catheter placement , the
pressure gradient across the stenosis was recorded and sev-
eral balloon inflations were performed with sufficient time
between inflations for resolution of any ischemic signs or
symptoms. After maximal correction of the pressure gra-
dient was obtained, the dilating catheter was removed and
repeat angiography performed .
When passage of the dilating catheter through a vein
graft was required, Judkins-type right coronary guiding
catheters , Amplatz-type guiding catheters or multipurpose
guiding catheters (29) were utilized to direct dilating cath-
eters into vein grafts . Preshaping of the guiding catheter
with a heat gun (Raychem) was occasionall y required to
achieve a proper seating of the guiding catheter in the orifice
of the vein graft. When passage of the standard dilating
catheter was not possible because of entrapment in side
branches or acute angulations, the use of a dilation catheter
with a guidewire system with directable tip was frequently
successful.
In the Zurich series , patients were given anticoagulant
therapy with Coumadin for 6 months . In most of the Emory
patients, aspirin, 325 mg/day , was utilized for 6 to 9 months
after angioplasty. Anesthetic management of patients for
angioplasty failure requiring emergency surgery included
monitoring of left ventricular filling pressure, cardiac output
and peripheral vascular resistance (30). Surgical and car-
dioplegic techniques have been previously described (31,32).
Results
Successes, failures and complications. Angiographic
success (> 30% reduction in stenosis) was obtained in 107
(88%) of 122 first attempts at transluminal angioplasty (Fig.
3). Mean stenosis calculated by the diameter method in the
107 successful procedures was reduced from 78 ± 13%
(mean ± standard deviation) to 25 ± 13% (probability [p]
< 0.000 I) and the pressure gradient from 49 ± 15 to II ± 8
mm Hg (p< 0.0001) . It was not possible to cross the stenosis
with the dilating catheter in II patients (9%) and 9 of these
II patients underwent elective coronary bypass surgery; 2
patients refused surgery and continued on medical treat-
ment. In three patients , passage of the dilating catheter
across the stenotic segment and subsequent balloon inflation
resulted in coronary artery dissection and vessel occlusion,
and emergency coronary bypass surgery was carried out.
One of the patients undergoing emergenc y surgery devel-
oped inferior lead Q waves on the electrocardiogram. The
other two patients undergoing emergency bypass surgery
had elevated peak serum creatine kinase (CK-MB values 66
and 31 international Uzliter, respectively ) but there was no
other clinical evidence of infarction and the patients ' con-
valescence was uneventful. One patient had a nonoccluding
coronary dissection and underwent elective coronary bypass
surgery.
Other complications were : CK-MB greater than 20 units
(two patients), prolonged ischemic pain requiring intraaortic
balloon pumping (one patient) and ventricular fibrillation
(two patients). There were no early deaths. One late death
occurred after an uncomplicated attempted angioplasty pro-
cedure with failure to cross a left anterior descending coro-
nary stenosis . The patient refused surgery and died suddenly
14 months later.
Seven patients underwent successful repeat angioplasty
because of recurrence of symptoms and restenosis of the
dilated site. Six of these patients had maintained an ac-
ceptable symptomatic status at last follow-up . At a mean
follow-up of 8.3 months, 88 patients (76%) had persisting
clinical success (remained free of angina or were in im-
proved condition). Initial angiographic success and long-
term outlook were significantly influenced by the location
of the stenotic segments as noted later.
Native coronary artery stenosis. Fifty-nine coronary
angioplasty procedures were performed in 57 patients for
stenosis of the native coronary arteries (Table I). Forty-
nine (83%) of these procedures were successful, with the
success rate being lowest in the right and diagonal coronary
arteries (68 and 67%, respectively) and highest in the left
anterior descending coronary artery (96%). Two patients
required emergency surgery because of right coronary artery
dissection and one patient had ventricular fibrillation during
the procedure. Mean diameter stenosis was reduced from
74 ± 12 to 26 ± 10% (p < 0.0001) and pressure gradient
Figure 3. Initial results in 122 first attempts at transluminal coro-
nary angioplasty in 116 patients who have had prior coronary
bypass surgery. Initial success is greater than 30% reduction in
diameter stenosis and improvement in symptoms .
/' Unable to Cross
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from 49 ± 17 to 12 ± 8 mm Hg (p < 0.0001 ). Four
patients developed angiographic restenosis and underwent
successful repeat angioplasty. One patient developed re-
stenosis after a second transluminal angioplasty and under-
wentcoronary bypass surgery. One patient had clinical evi-
dence of restenosis with recurrence of angina and a positive
treadmill test but refused restudy.
Theref ore. of 37 patients f ollowed up at least 6 months
after angioplasty, 5 had clinical or angiographic evidence
of restenosis. A total of 26 patients underwent repeat cath-
eterization at a mean of 6.6 months after angioplasty; re-
stenosis was present in 4 (15%). The mean diameterstenosis
at repeat study in the 22 patients without restenosis was
25%, which was not significantly different from that present
in these patients immediately after angioplasty (29%) . Of
the 14 patients followed up at least 6 months who were not
recatheterized, 6 were asymptomatic, 4 had minimal angina
and 4 had class II to III angina (Canadian Cardiovascular
Society classification), but were in improvedcondition co m-
pared with their status before angioplasty. At a mean follow-
up of 7.7 months, 46 patients (94%) with successful dilation
maintained satisfactory clinical status and were angina-free
or in improved condition from their clinical state before
angioplasty (Table I) .
Of the 59 stenotic native coronary artery segments in
which angioplasty was attempted, 25 (42%) were in vessels
to which the vein graft had become stenotic or had closed.
These lesions therefore antedated bypass surgery, which was
performed a mean of 15 (range 3 to 60) months earlier. The
primary success rate of angioplasty in these stenoses was
88%. In 32 attempts to perform angioplasty, the stenosis
had developed after bypass surgery, which was performed
a mean of 51 (range 7 to 138) months earlier. The primary
success rate in these stenoses was 78%. In two instances,
the stenotic segments treated by angioplasty were lesions
present at surgery but not bypassed.
Distal anastomosis (saphenous vein to coronary artery
junction). Thirty-four patients underwent transluminal an-
gioplasty of stenoses involving the anastomosis of a saphe-
nous vein to a coronary artery. In 25 patients (74%), the
vein graft was to the left anterior descending coronary artery
and in 6 patients (18%) it was to the right coronary artery.
Twenty-two patients underwent angioplasty of the distal
anastomosis within 6 months and 25 (74%) within I year
after bypass surgery (Fig. 2). In 32 patients (94%), the
procedure was successful (Fig. 4). Stenosis was reduced
from 83 ± 11 to 20 ± 12% (p < 0.0001) and pressure
gradient from 50 ± 13 to II ± 10 mm Hg (p < 0.0001 ).
In the early clinical experience (Patient 4 in this group), it
was not possible to enter a saphenous vein with a dilating
catheter accounting for one failure and another patient re-
quired emergencycoronarybypass surgery due to a localized
coronary dissection producing total occlusion.
Four of 32 patients with initial success developed re-
stenosis; 3 had successful repeat angioplasty and I under-
went coronary bypass surgery without a second attempt at
angioplasty. Three patients had attempted angioplasty at
another site 4 to 9 months after the initial procedure. Two
of these procedures were successful; one stenosis could not
be crossed and this patient underwent elective coronary by-
pass surgery without complication. There were no early or
late deaths. At a mean follow-up of 10 months, 30 (88%)
of 34 patients maintainedsatisfactory clinical status (Fig. 4).
Figure 5 shows the results of coronary arteriography in
19 patients perf ormed 1 to 15 months (mean 6.6) after
transluminal angioplasty of the distal saphenous vein an-
astomosis . In the 15 of 19 patients who did not develop
overt restenosis, there was no difference between the im-
mediate postangioplasty residual stenosis (20%) and that
present on restudy (15 %). Restenosis of the distal anasto-
moses occurred in 4 (18%) of the 22 patients followed up
at least 6 months after angioplasty and in 4 (21%) of the
19 undergoing repeat coronary arteriography to assess pat-
ency. Follow-up study of three patients with repeat angio-
Table 1. Transluminal Angioplasty of Native Coronary Arteries
Initial Success Initial Failure Follow-up After Initial Success
CABS Restenosis ContinuedVessel
Treated No. % Emer Elec Med Re-PTCA CABS Med Success
LCx 10 of II 91 0 I 0 1 0 0 10
DIAG 2 of 3 67 0 0 I 0 0 0 2
LAD 23 of 24 96 0 I 0 2 I I 21
LMCA oof I 0 0 I 0 0 0 0 0
RCA 13 of 19 68 2 3 I 1 1 0 12
SP I of I 100 0 0 0 0 0 0 I
Total 49 of 59 83 2 6 2 4 2 I 46 of 59
CABS = coronary bypass surgery; DIAG = diagonal coronary artery; Elec = elective; Emer = emergency, LAD = left anterior descend109
coronary artery; LCx = left circumflexcoronary artery: LMCA = left mam coronary artery; Med = medical therapy: PTCA = percutaneous translurnmal
coronary angioplasty; RCA = right coronary artery; SP = septal perforating artery.
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PTCA DISTAL ANASTOMOSIS
Time After Angioplasty (months)
tornosis and native coronary artery in the same patient and
Figure 7 shows the late results of dilation of the distal
anastomosis.
Saphenous vein independent of anastomoses. In 23
patients, transluminal angioplasty was attempted for stenosis
in the saphenous vein graft proper (not involving proximal
or distal anastomoses). In II patients, the graft supplied the
left anterior descending and in 10 the right coronary artery.
Mean interval between coronary bypass surgery and trans-
luminal angioplasty was 27 months (Fig. 2). In 22 patients
(96%), initial success was achieved with a reduction of
stenosis from 82 ± 10 to 30 ± 15% (p < 0.0001 ). One
patient experienced ventricular fibrillation during the pro-
cedure and underwent successful cardioversion. There were
no other complications and specifically noevidence of distal
embolization from the dilated segment. Nine patients de-
veloped restenosis, either angiographically confirmed (eight
patients)or evidenced by early recurrenceof symptoms (one
patient). Thirteen patients continued to have satisfactory
symptomatic status (Fig. 8) at a mean follow-up of 8.7
months. Figure 9 shows angioplasty of a mid-saphenous
vein graft.
Seventeen patients with initially successful dilation were
followed up 6 months or more after angioplasty. Eight of
these patients (47%) had satisfactorysymptomatic status and
no documented restenosis at last follow-up. Thirteen of the
17 patients had repeat angiography at 6 months after an-
gioplasty) and 8 patients (61% ) had closure or restenosis of
the vein graft. In the fi ve patients with a patent graft, the
residual stenosis (32%) was not different from that present
immediately afte r angioplasty (30%).
The infiuence of the time interval between surgery and
angioplasty on restenosis of the mid-saphenous vein was
examined. Of the 12patients undergoing angioplasty within
I year of surgery, 7 (58%) had evidence of restenosis, 3
had documented patency more than 6 months postangio-
plasty and 2 have not had restudy. Six patients underwent
angioplasty I to 3 years postoperatively; two developed
restenosis, one had documented patency over 6 months after
angioplasty and three have not been restudied. Of the four
patients who underwent angioplasty more than 3 years post-
operatively, all are doing well clinically but none have had
repeat angiography.
Other sites. In fi ve patients, transluminal angioplasty
was attempted for stenosis of the anastomosis of the sa-
phenous vein to the aorta (proximal anastomosis). In one
patient with extremely severe stenosis and little flow across
the stenotic segment, it was not possible to enter the sa-
phenous vein graft with a dilating catheter and this patient
underwent elective coronary bypass surgery. Four patients
(80%) had an initially successful angioplasty with reduction
of mean stenosis from 84 to 39%. One of these four patients
had recurrence of symptoms I month later and underwent
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Figure 4. Results of transluminal angioplasty in patients with
stenosis of the distal anastomosis (saphenous vein to coronary
artery). CCS = Canadian Cardiovascular Society classification of
angina pectoris; other abbreviations as in Figure 2.
plasty showed good patency in two patients at 9 months (5
and 10% stenosis, respectively) and the third patient is
asymptomatic 2 months after angioplasty.
The results ofangioplasty in patients who underwent the
procedure within I year of surgery were characterized by
a high primary success rate (24 of 25, 96%). absence of
any complications during the procedure and excellent pat-
ency. Two patients who developed restenosis underwent
dilation again. At last follow-up, 18 of 25 patients in this
subgroup were asymptomatic, 5 were in class I and 2 were
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2 3
Mean Follow' uP 10 mo .
Figure 5. Angiographic evaluation of the distal anastomosis (sa-
phenous vein to coronary artery) after transluminal angioplasty.
Dashed lines indicate repeat angioplasty.
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Figure 6. A 37 year old woman had placement
of saphenous vein grafts to the left anterior de-
scending and posterior descending coronary artery
in July 1980. Unstable angina recurred in October
1980 and high grade stenosis was present at the
junct ion of saphenous vein graft to left anterior
descending coronary artery (panel A, top). The
circumflex coronary artery had minimal disease
(panel A, bottom). The saphenous vein graft to
posterior descending coronary artery was patent.
Transluminal angioplasty of the distal anastomosis
on October 20, 1980 was succes sful (residual ste-
nosis 5% and pressure gradient 8 mm Hg) . Dis-
abling angina recurred in July 1981. Coronary
angiography (panel B) showed a widely patent
distal anastomosis but high grade stenosis of the
circumflex coronary artery unrespons ive to nitro-
glycerin . Transluminal angioplasty of the circum-
flex stenosis on July 8, 1981 was effective (re-
sidual stenosis 5% and pressure gradient 6 mm
Hg). Restudy in January 1982 (panel C) shows a
widely patent distal anastomosis and circumflex
coronary artery . The saphenous vein graft to pos-
terior descend ing coronary artery was also patent.
The patient remained asymptomatic at last follow-
up in March 1983.
arteriography at 8 months after angioplasty showing 10%
res idual stenosis and this patient is asymptomatic 13 months
after angioplasty . The two remaining patients are asymp-
tomatic 1 and 5 months, respectively, after angioplasty .
Transluminal angioplasty was attempted in one patient
with stenosis of the mid-portion of an internal mammary to
left anterior descending coronary artery graft placed 18 months
previously. It was not possible to pass the stenosis with a
dilating catheter and coronary bypass surgery was recom-
mended.
Discussion
Initial results of angioplasty in patients with prior
coronary bypass surgery. The ro le of transluminal angio-
pla sty in patients with prior co ronary bypass grafting ha s
Figure 7. A 57 year old man underwent saphenous
vein bypass grafting to the distal anterior descend-
mg artery in January 1981 and developed disabling
angina pectoris in July 1981. Coronary angiography
(A) showed high grade stenosis at the junction of
the saphenous vein to the left anterior descending
coronary artery . Transluminal angioplasty on July
27, 1981 was successful (residual stenosis 13%) and
restudy 9 months later showed a widely patent distal
anastomosis (B). The patient remained asympto-
matic at last follow-up in March 1983.
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Mean Follow-up 8.7 mo.
Figure 8. Diagram of patient outcome after transluminal angio-
plasty of stenoses in saphenous vein grafts not involving the prox-
imal or distal anastomosis. Abbreviations as in Figure 4.
not been previously defined. This nonoperative method of
improving blood flow has been widely applied primarily in
patients with single vessel coronary disease. In the first
1,116 cases reported in the National Heart, Lung, and Blood
Institute Registry, 62% of the procedures were initially suc-
cessful and 6.6% required emergency coronary bypass sur-
gery (19). The in-hospital mortality rate was 0.7% in pa-
tients without prior bypass surgery and 8.1% in patients
with prior bypass surgery (5 of 62 cases). This significantly
higher figure is based on one death directly related to an-
gioplasty, three deaths probably related to angioplasty and
one death probably unrelated to angioplasty. Initial success
rate and nonfatal complications were not reported for pa-
tients with previous bypass surgery.
In the present report, the initial success rate of translu-
minal angioplasty in patients with prior bypass surgery (88%)
was similar to our total experience with angioplasty during
the same time period (87% success rate in 1,400 patients).
As has been previously reported (15,16,18), the success rate
was significantly influenced by the location of the stenotic
segment. Transluminal angioplasty of stenoses in the left
anterior descending coronary artery, the circumflex coronary
artery and vein grafts had a high primary success rate (91
of 97 patients, 94%) and almost no complications. More
problems were encountered in the right coronary artery be-
cause increased tortuosity resulted in difficulty crossing
stenoses and a greater tendency for coronary artery dissec-
tion. Attempted angioplasty of the right coronary artery
accounted for 40% of initial failures and 66% of emergency
operations, but only 15% of total procedures. This parallels
our experience in patients who have not had prior coronary
bypass surgery. Initial success rate of transluminal angio-
plasty is influenced by operator experience, case selection
and availability of an array of catheter systems to overcome
problems. With the use of a steerable catheter system, we
have been able to increase the success rate in the right
coronary artery to 88% during the past year.
The degree of correction ofstenosis in the present report
(mean residual stenosis of 25%) compares favorably with
previous reports of residual stenosis of 34% (15,16) and
31% (18). Factors possibly contributing to this improved
result are the availability of balloon catheters which with-
stand higher pressures and larger balloons (3.7 and 4.2 mm)
that may be used in large arteries or vein grafts. Correction
of stenosis was most complete in distal anastomoses and
least complete in the saphenous vein proper.
Complications of angioplasty in postoperative patients
were significantly lower than previously reported (15,16,18).
But these previous reports dealt with initial experiences,
whereas the present report concerns a subgroup of 1,400
angioplasty procedures performed by three operators. Com-
plication rates in our total experience are similar to that
reported for the subgroup of postoperative patients. Distal
embolization was not observed in vein graft dilations despite
the known friability of vein graft atheroma (33); case se-
Figure 9. A 51 year old man had bypass surgery
in 1973 and mild stable angina until March 1982
when angina developed with minimal effort and at
rest. Coronary angiography showed high grade fo-
cal stenosis in the mid-saphenous vein graft to the
left anteriordescendingcoronary artery (A). Trans-
luminalangioplastyon March II, 1982reduced the
stenosis to 10% (B). The patient returned to full
activity and has remained virtually asymptomatic
(functional class I) at last follow-up in March 1983.
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lection may be important in avoiding this complication. In
this report , only patients with single, localized , smooth vein
graft stenoses were attempted. Only 4 of23 vein grafts were
implanted for more than 5 years.
Late results of angioplasty in patients after coronary
bypass. Most of our patient s undergoin g angioplasty had
a single major coronary stenosis that was corrected with
subsequent improvement in symptomatic status. In 19 pa-
tients, recurrence of symptoms signalled restenosis of the
segment that was dilated . The peak occurren ce of restenosis
was at 2 to 4 month s after angioplasty. In those patients
with native coronary artery dilation who were followed up
at least 6 months after angioplasty, 14% had restenosis or
recurrence of symptoms. This restenosis rate is less than
that experienced in native coronary arteries in our patients
who were not operated on (approximately 30%) and that
reported by others of 30% (34) and 47% (35) in relatively
small series of consecutive patients . Further evaluation of
the patients who have not yet undergone postangioplasty
angiography may uncover additional patients with reste-
nosis. In our patients not surgically treated , we observed
that restenosis was less common in patients with old stenoses
as manifested by a long history of angina. This series of
surgically treated patients has a high proportion of patients
with old stenoses and this factor may contribute to the pat-
ency observe d.
Maintenance ofpatency of the distal (vein graf t to coro-
nary artery) anastomosis after angioplasty was excel/ent.
Currentl y, little is known of the incidence or pathologic
basis of stenosis at this site . Three possible mechanisms
have been proposed: 1) compression or loss of arterial lumen
by utilization of the arterial wall within the anastomosis; 2)
thrombosis at the anastom osis; and 3) dissection ofthe native
coronary artery (36-38). Both intimal proliferative changes
and occlusive thrombi occur with greater frequency at the
distal anastomosis than at other vein graft sites (39,40) .
Moore et al. (41), in analyzing mechanisms of occlusion in
the distal anastomo sis, concluded that half were caused by
compression of the arterial lumen and the remainder by
thrombosis. Observations in our cases offer no solution to
the questions regardin g pathologic changes, but make note
of the development of a characteristic lesion appearing 2 to
6 months postoperatively producing high grade stenosis at
the distal anastomosis . This lesion is almost completely,
and in most cases , permanently reversed by balloon
angioplasty.
Patency was less fa vorable in the mid-saphenous vein
graft. Late angiographic evaluation was most complete in
the group of patients who had angioplasty within 1 year of
surgery; 58% had restenosis. In most patients who had an-
gioplasty more than I year postoperatively , follow-up is
short; therefore, there is little informati on about restenosis
rates in these patients although only 2 of the 10 have known
restenosis. Morphologic changes in implanted saphenous
vein grafts are dissimilar from those in native coronary
arteries and to some extent reflect the time since implan-
tation . Diffuse intimal thicken ing is universally found in
vein grafts that have been in place for more than I month
(33,37-43). High grade narrowing or total occlusion from
intimal fibrous proliferation is rarely reported (33,38,39,42),
but has been noted to occur about 2 em from the aortic
anastomosis (38). Stenosis at this site was observed early
in this series and was attributed to surgical trauma .
Because atherosclerosis of vein graf ts occurs quite late
after surgery (33.39), it is presumed that patients undergo-
ing angioplasty within I year of surgery have fibrous intimal
proliferation as a pathologic basis of the stenosis and that
recurrent stenosis postangioplasty is due to a continuation
of this process . Atherosclerosis is present in a majority of
vein grafts examined over 3 years postoperatively (33,37,
39,43) and stenosis in vein grafts at that time is commonly
atherosclerotic. Whether the response to angiopla sty in vein
grafts dilated several years postoperatively will be more
similar to that observed in the native circulation remains to
be seen.
Risk of angioplasty. The primary risk of transluminal
angioplasty is sudden closure of the vessel one attempts to
dilate . This occurred in our series in three patients , resulting
in emergency reoperation. In the National Heart , Lung, and
Blood Institute Registry , 2 of II patients whose deaths were
definitely or probably related to angioplasty experienced
cardiovascular collapse with anesthetic induction and I pa-
tient had refractory hypotension (19). In patients who under-
went emergency surgery for failed angioplasty in our insti-
tution, measurement of peripheral vascular resistance
commonly revealed marked vasodilation. Administration of
calcium antagonists and nitrates to overcome coronary artery
spasm is the presumed cause and large doses of vaso-
constrictors were required to support blood pressure in some
patients. Anesthesia in these patients with significant on-
going myocardial ischemia was provided with minimal
amounts of potent , nonmyocardial-depressant narcotics. In-
traaortic balloon pumping is almost routinely utilized in this
instance.
Major determinants of the risk of angioplasty are: I)
likelihood of coronary artery closure; 2) quality of left ven-
tricular function and mass of myocardium supplied by the
attempted artery; 3) status of other coronary arteries; and
4) quality and availability of anesthetic and surgical backup
teams.
Comparison of angioplasty with reoperation f or recur-
rent symptoms. Many patients who experience a recurrence
of disabling angina pectoris after bypass surgery are not
candidates for transluminal angiopla sty. A comparison of
results in our study group with reoperative results is difficult
because of dissimilar patient populations . It appears, how-
ever, that repeat surgical revascularization is usually not
extensive (1.6 grafts per patient at the Cleveland Clinic)
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(II ), operative mortality rates are significantly increased
and complications are more frequent. At Emory University
Hospital and at the Cleveland Clinic , operative mortality
rate in reoperations was four times that of first operations.
perioperative infarctions occurred three times more fre-
quently and the risk of infection and blood transfusion-
related complications was significantly higher (II ). In our
experience and that of others (2 1). the cost of surgery is
three times that of transluminal angioplasty , not including
the added cost of surgical convalescence. Productivity is
higher with angioplasty because of the short convalescence
and reduced morbidity (22) . The opportunity to undergo a
second operation is a valuable asset in this progressive dis-
ease . In the brief time frame of this study , several patients
have developed more than one new major coronary artery
stenosis that would have required reoperation. By undergo-
ing one or more transluminal angioplasty procedures they
have successfully retained the option of undergoing a second
operation .
Clinical implications. We believe that transluminal
coronary angioplasty is a viable alternative to reoperative
surgery when the anatomy is favorable and excellent an-
esthet ic and surgical backup is available . Success of trans-
luminal angioplasty is largely determined by the location of
the stenotic segment. Tran sluminal angioplasty is the treat-
ment of choice for stenosis of the saphenous vein to coronary
artery anastomosis and for certain patients with native coro-
nary artery stenosis. Although there is a high initial success
rate in stenosis of the proximal saphenous vein anastomosi s
and mid-saphenous vein graft. further patient follow-up is
needed to determ ine the role of transluminal angioplasty for
these problems. Patient s experiencing recurrence of angina
postoperatively should be considered for prompt coronary
angiography to identify high grade stenotic segment s ame-
nable to transluminal angioplasty before there is progression
of stenosi s to total vessel occlusion.
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